InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
81.98
(
-0.18%
)
Bitcoin
66,217.87
(
-0.63%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: rkrw post# 7704

Thursday, 05/05/2011 2:09:21 PM

Thursday, May 05, 2011 2:09:21 PM

Post# of 80490

Mutations only arise *after* treatment. Same as with BCR ABL drugs.


This is far less definitive than your statement implies.

"Evidence has emerged suggesting that cells bearing the T315I mutation may be present *early* in the disease and undergo expansion following elimination of their drug-sensitive counterparts."

See "Targeting the Resistance in CML" http://www.hematology.org/Publications/Hematologist/2010/4827.aspx
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up